INTRODUCTION
Gram-negative bacteria-induced sepsis often contributed to the large percentage of deaths occurs in hospitalized patients [1] . Most of the toxic manifestations induced by 
Salvia miltiorrhiza BUNGE or Danshen is officially listed in the Chinese
Pharmacopenia and is best known for its unique application in the treatment of coronary heart diseases, hemorrhages, menstrual disorders and miscarriages, renal diseases, myocardial infarction and hypertension [14] [15] [16] [17] . The protection of SM has been associated with its effects on cerebral edema, monoamines, neuropeptides, and neurotransmitter amino acids, thromboxane A2, peroxidation and downregulation of c-fos gene expression [18] . The plant is a rich source of polyphenols, with an excess of 160 polyphenols has been identified [19, 20] . The active constituents of SM can be classified into two groups. The first group consists of the phenolic compounds slavianolic acid and lithospermate B; and the second group consists of the abietane type-diterpene quinone pigments tanshinone I, tanshinone IIA, tanshinone IIB and the cryptotanshinone [19] [20] [21] , rosmarinic acid and lithospermic acid [22] . The therapeutic effect of SM on heat stroke, myocardial ischemia and infarction has been largely attributed to the endothelium-dependent vasodilatory and hypertensive properties of the tanshinones [19] [20] [21] and lithospermic acid B [23] . The salvianoic acids A, B, and C of SM have also been shown to capable of protecting liver microsomes, hepatocytes and erythrocytes against oxidative damage [22] and recently showed to protect human neuroblastoma cells against cytotoxicity. Rosmarinic acid is a naturally occurring polyphenol with anti-oxidative and anti-inflammatory activities [25] [26] [27] and its salts are reported to have anti-HIV activities [28] . SM or Danshen is frequently used as a decoction or intravenous injection in the treatment of various systemic and surgical infections in the hospitals of China.
Successful outcomes have been observed in treating infections of hands and feet, erysipelas, ostemyelitis, matitis, cellulitis, otitis externa acute tonsillitis as well as infections of bone and joints but the anti-infection mechanistic actions have not been investigated. The present study sought to investigate the protective mechanisms of SM 4 on gram. By using an in vivo LPS-challenged mouse model, we have demonstrated that SM exhibits ant-inflammatory properties and suppressed the pro-inflammatory TNF-α cytokine release and liver damage induced by LPS in mice. The ability of SM to suppress LPS-induced pro-inflammatory TNF-α cytokine is further supported by the two separate in vitro experiments conducted with human peripheral blood leukocytes and macrophage RAW 264.7 cell line. The present study thus helps to explain some known therapeutic properties of SM.
MATERIALS AND METHODS

Reagents
The trade name of Salvia miltiorrhiza (SM) is H-care (batch no. 3HC1980808, supplied by Winsor Health Products Ltd., Hong Kong). Reagents for cell culture, Trizol TM , and PCR primers were purchased from Invitrogen (Carlsbad, Ca). 
Mouse-treatment of SM and LPS
Male BALB/c mice aged 6-8 wk were obtained from the animal house of the department of Zoology, the University of Hong Kong. All mice were kept at 22 o C and 55% relative humidity in a 12-hour day/night rhythm with free access to laboratory chow and water. The mice were randomly divided into 2 groups of 12 animals and designated to receive orally either 0. 
Biochemical analysis of blood samples in mouse
After 24 hours of LPS injection, all mice were anesthetized with carbon dioxide and killed by exsanguination via heart puncture. Blood were collected from the heart by using a 25-gauage syringe. The plasma was stored at 4°C until further analysis of TNF-α, lymphocyte subsets immunophenotyping and glutamate-pyurate transaminase (GPT) activity by ELISA, flow cytometry and spectrophotometry, respectively.
Preparation of mouse peripheral blood leukocytes (PBL) and splenocytes
Mouse peripheral blood leukocytes were isolated by using the red blood cell lysing buffer. 100 μl of blood sample was diluted (1:20) with red blood cell lysing buffer and placed at room temperature for 3 minutes. The mixture was centrifuged at 400 g for 5 minutes and the supernatant was aspirated. The pellet contained the PBL was washed with phosphate buffer solution (PBS) and resuspended in 50 μl blocking buffer (PBS, 1% BSA and 0.1% sodium azide) on ice.
Splenocytes were prepared by dissociate the spleen in the cell strainer using a syringe plunger. The exudates were centrifuged at 400 g for 5 minutes and the red blood cells were removed by adding 2 ml of red blood cell lysing buffer. After washing with PBS, the splenocytes (1 x 10 6 cells) were resuspended in 50 μl blocking buffer on ice.
Immunophenotyping of mouse peripheral blood leukocytes and splenocytes by flow cytometry
Mouse PBL and splenocytes were pre-incubated with 0.5 μg of anti-CD16/CD32
antibody for 15 minutes on ice to block the Fc receptors. Their lymphocyte subsets μl of blocking buffer was added to the mixture.
Determination of glutamate-pyurate transaminase (GPT) activity in mouse serum
To determine glutamate-pyurate transaminase (GPT) activity in serum, 100 μl of serum was mixed with 500 μl of preincubated (37°C) GPT substrate solution (1.8 mM α-ketoglutarate and 200 mM DL-alanine in 0.1 M phosphate buffer, pH 7.2) in test tube.
The mixture was then incubated in a water bath at 37°C for 30 minutes. 500 μl of 1 mM 2,4-dinitrophenylhydrazine (DNP) was added and the mixture was placed at room temperature for 20 minutes. Finally, 5 ml of 0.4 M NaOH was added and kept at room temperature for 5 minutes for color development. Absorbance of the mixture was measured at 505 nm.
The in vitro treatment of LPS and SM on human peripheral blood leukocytes (PBL)
Fresh human PBLs were isolated buffy coats obtained from healthy blood donors.
Briefly, PBLs were prepared by using red blood cell lysing buffer (NH 4 Cl 0.83%, NaHCO 3 0.084%, EDTA 0.003%). The blood was diluted (1:45) with red blood cell lysing buffer and placed at room temperature for 3 minutes. Then the mixture was centrifuged at 400 g for 5 minutes. The supernatant was decanted and the cell pellet was resuspended and washed twice in complete RPMI 1640 medium. The cells were counted by Coulter Multisizer and seeded at a cell density of 2 x 10 5 cells per well in 96
well tissue culture plates. The cells were treated with or without LPS (10 μg/ml) and SM (0, 100 and 400 μg/ml) for 72 hours. Supernatant was collected at 72 hours for TNF-α detection by ELISA.
In vitro treatment of Raw 264.7 macrophage cell line with LPS and SM
The Raw 264.7 macrophage cell line (originally from the American Type Culture Collection) was kindly donated by Dr. R.C.C. Chang (The University of Hong Kong, HKSAR, China). The cells were grown in 25cm 2 flasks in DMEM containing 10% heat inactivated fetal bovine serum, 100 U/ml penicillin/streptomycin and 1% fungizone at 37°C in 5% CO 2 incubator. For all experiments, cells were grown to ~80% confluence and were subjected to no more than 25 cell passages. The cells (5 x 10 6 cells/25cm 2 flasks) were pre-incubated with SM (0, 100 and 400 μg/ml) for 16 hours before exposed to LPS (1 μg/ml). Supernatant and cells were collected 3 hours after exposure to LPS for the detection of TNF-α by ELISA and RT-PCR.
ELISA assay for TNF-α measurement
Commercial ELISA kits for mouse/human TNF-α were used. The cytokine production was analyzed by sandwich ELISA. Briefly, ELISA plates were coated with appropriate capture antibodies diluted in sodium bicarbonate buffer (0.1M, pH 9.5) overnight at 4°C. Plates were washed five times with washing buffer (0.05% in PBS) between steps. The wells were blocked with 200 μl of assay diluents (10% FBS in PBS) for 3 hours at room temperature and 100 μl of supernatant or serum were added and incubated for 2 hours. Next, 100 μl of the working detector (detection antibody and avidin-horseradish peroxidase conjugate) was added and incubated for 1 hour at room temperature. Finally, color development was achieved by enzymatic reaction brought by incubation with 100 μl TMB substrate solution for 30 minutes and the reaction was terminated by adding 50 μl of 2 M sulphuric acid. The absorbance was measured on a microplate reader at 450 nm.
Analysis of TNF-α mRNA levels in Raw 264.7 macrophage cell line by RT-PCR
Total RNA was isolated from Raw264.7 cells according to the instructions of the manufacturer. Briefly, cells were lysed by adding 2 ml of Trizol TM to the flask. Total 
Statistical analysis
Statistical significance of the data was determined by one-way analysis of variances (ANOVA). Results were compared by Student's paired t test with a two-tailed probability value p< 0.05 taken as significant. Upon LPS challenge, the plasma level of TNF-α was enhanced by three-fold.
RESULT
LPS-induced elevation serum TNF-α in mice was significantly (p<0.05) reduced from 146 pg/ml to 85 pg/ml with SM treatment.
The ability of SM to reduce TNF-α release was further tested by carried out two independent in vitro experiments using different cells of the immune response. Figure   3 shows that the secretion of TNF-α was reduced (p< 0.01) by SM dose-dependently in both Control and LPS treated human peripheral blood leukocytes. At 100 μg/ml of SM, the level of TNF-α reduced by 30% and 35% in the Control and LPS treated PBL, respectively.
The ability of SM to suppress TNF-α is further confirmed by the Raw264.7 macrophages cell line. Figure 4A shows that only small amounts of TNF-α were detectable by the ELISA assay in the supernatant of the non-LPS treated Raw 264.7 cells. Upon LPS challenge, the TNF-α level of the cultured macrophages cells (without SM treatment) was enhanced by three hundred-fold. SM at 100 μg/ml and 400 μg/ml dose level significantly suppressed the TNF-α release by 15% and 30%, respectively. Figure 4B presented the RT-PCR data indicating SM inhibits LPS-induced TNF-α release likely at the mRNA level.
Elevation of CD4/CD8 ratio in spleen and peripheral blood mononuclear cells of LPS-treated mice by SM
Challenging the BALB/c mice with LPS derived from Escherichia allowed us to assess both humoral and cell-mediated immune resistance. Immunophenotying by flow cytometry of both peripheral blood T-lymphocytes and splenocytes clearly illustrated that mice receiving SM treatment manifested a lower degree of injury upon LPS challenge. Following LPS challenge, the absolute lymphopenia of CD3+ lymphocytes was observed. Upon stimulation of LPS, there is usually a massive decline in CD4+ T helper cells with the CD8+ T cytotoxic cells either remain unchanged or elevated (Ertel and Faist, 1989) . This leads to a conversion of the CD4/CD8 ratio to decrease dramatically. In this study, we found that LPS induced similar changes in both T-lymphocytes (Table 1 ) and splenocytes (Table 2) as shown by a decrease in CD4+ and CD8+ cells accompanied by a decrease in the CD4/CD8 ratio.
Suppression of LPS-induced GPT Level by SM
Plasma glutamate-pyruvate transaminase (GPT) level was used as an index of hepatotoxicity. in this study has yet to be determined. The inhibition on pro-inflammatory cytokine TNF-α activity, however, has been regarded as an important anti-atherosclerotic property of SM in treatment of acute coronary syndromes [36] . Both aqueous ethanolic extract (SME) and the water-soluble antioxidant, savianolic acid B (Sal B) of SM, have been shown to inhibit TNF-α induction on nuclear factor kappa B (NF-κB) expression in human aortic endothelial cells (HAECs) line [37] .
Immunophenotyping by flow cytometry of both peripheral blood leukocytes and splenocytes in mice illustrated for the first time that SM can play an important role in cell-mediated immune resistance. Following endotoxin challenge, the absolute lymphopenia of CD3+ lymphocytes was observed. In both splenocytes and T-lymphocytes, the helper cell (CD4+) and suppressor cell (CD8+) populations were greatly reduced after LPS treatment with the CD4+ population decreased in a greater extent than CD8+. The absolute percentages of lymphocyte subsets from spleen and blood were slightly different and their response to SM treatment was not identical. On the whole, SM improved the CD4+/CD8+ ratio; and this ratio of lymphocytes in the blood were more sensitive to both LPS and SM than that of the spleen. 
